Keywords
innovations
quantum medicine
bioquantum medicine
bioquantum therapy
bioresonance therapy
neuroendocrine system
personalized treatment
multidisciplinary approach
complementary medicine
How to Cite
Abstract
The article provides an interdisciplinary review of the potential of quantum approaches in the complex treatment of chronic pancreatitis. It considers modern ideas about the pathogenesis of the disease, considering the role of neuroendocrine regulation, chronic inflammation, and disorders of intercellular interaction. It identifies the theoretical foundations of quantum biology and bioinformation processes that can affect the physiological mechanisms of the body. It analyzes the results of clinical observations and scientific publications on the use of bioquantum and bioresonance therapy in functional disorders of the gastrointestinal tract. Particular attention is paid to the advantages of this approach: non-invasiveness, accessibility, compatibility with other pathological conditions, impact on the psychosomatic sphere, safety, and the possibility of personalized treatment. The feasibility of integrating bioquantum technologies into multidisciplinary treatment strategies based on the principles of evidence-based medicine, bioinformatics, and an individual approach is argued. Promising directions for further research are identified and the need for legal regulation in the field of quantum medicine is emphasized.
References
1. Maev I.V., Bideeva T.V., Kucheryavyy Y.A. et al. Pharmacotherapy of chronic pancreatitis in terms of current clinical recommendations. Terapevticheskii Arkhiv. 2018. Vol. 90. Iss. 8. P. 81–85. DOI: https://doi.org/10.26442/terarkh201890881-85.
2. Beyer G., Hoffmeister A., Lorenz P. et al. Clinical practice guideline—Acute and chronic pancreatitis. Deutsches Ärzteblatt International. 2022. Vol. 119. Iss. 30–31. P. 523–531. DOI: https://doi.org/10.3238/arztebl.m2022.0223.
3. Cohen S.M., Kent T.S. Etiology, diagnosis, and modern management of chronic pancreatitis: A systematic review. JAMA Surgery. 2023. Vol. 158. Iss. 4. P. 357–368. DOI: https://doi.org/10.1001/jamasurg.2023.0367.
4. Conwell D.L., Lee L.S., Yadav D.S., et al. American pancreatic association practice guidelines in chronic pancreatitis: Evidence-based report on diagnostic guidelines. Pancreas. 2014. Vol. 43. Iss. 8. P. 1143–1162. DOI: https://doi.org/10.1097/MPA.0000000000000237.
5. Yadav D., Lowenfels A.B. The epidemiology of pancreatitis and pancreatic cancer. Gastroenterology. 2013. Vol. 144. Iss. 6. P. 1252–1261. DOI: https://doi.org/10.1053/j.gastro.2013.01.068.
6. Nevzghoda O., Osyntseva A., Shapovalova V. et al. Optimization of pharmacotherapy for chronic pancreatitis: use of ABC/VED analysis in marketing and pharmacoeconomic studies. Proceedings of Shevchenko Scientific Society Medical Sciences. 2025. Vol. 77. Iss. 1. P. n/a. DOI: https://doi.org/10.25040/ntsh2025.01.16.
7. Shapovalova V. Forensic and pharmaceutical risks in the organization of pharmacotherapy of COVID, post-COVID and long-COVID disorders. SSP Modern Pharmacy and Medicine. 2022. Vol. 2. Iss. 4. P. 1–24. DOI: https://doi.org/10.53933/sspmpm.v2i4.69.
8. Majumder S., Chari S.T. Chronic pancreatitis. Lancet. 2016. Vol. 387. Iss. 10031. P. 1957–1966. DOI: https://doi.org/10.1016/S0140-6736(16)00097-0.
9. Titarenko I. Innovative Digital Medical Technologies: History, Development, Trends (Retrospective Data Review 1995–2024). SSP Modern Pharmacy and Medicine. 2025. Vol. 5. Iss. 2. P. 1–15. DOI: https://doi.org/10.53933/sspmpm.v5i2.181. URL: https://ssp.sreif.us/index.php/mpm/article/view/181
10. Gerber R., Vibrational Medicine: The #1 Handbook of Subtle-Energy Therapies. Bear & Company, 2001. 608 p. ISBN 9781879181588
11. Titarenko I. Application of Innovative Digital Medical Technologies of Bioquantum Medicine and Therapy in Elimination of Allergy Symptoms. SSP Modern Pharmacy and Medicine. 2024. Vol. 4. Iss. 3. P. 1–10. DOI: https://doi.org/10.53933/sspmpm.v4i3.156
12. Braganza J.M., Lee S.H., McCloy R.F. et al. Chronic pancreatitis. Lancet. 2011. Vol. 377. Iss. 9772. P. 1184–1197. DOI: https://doi.org/10.1016/S0140-6736(10)61852-7.
13. Whitcomb D.C. Genetic risk factors for pancreatic disorders. Gastroenterology. 2013. Vol. 144. Iss. 6. P. 1292–1302. DOI: https://doi.org/10.1053/j.gastro.2013.02.048.
14. DiMagno M.J., Dimagno E.P. Chronic pancreatitis. Curr Opin Gastroenterol. 2006. Vol. 22. Iss. 5. P. 487–497. DOI: https://doi.org/10.1097/01.mog.0000236002.09871.b2
15. Conwell D.L., Lee L.S., Yadav D., et al. American Pancreatic Association Practice Guidelines in Chronic Pancreatitis: evidence-based report on diagnostic guidelines. Pancreas. 2014. Vol. 43. Iss. 8. P. 1143–1162. DOI: https://doi.org/10.1097/MPA.0000000000000212
16. Machicado J.D., Yadav D. Epidemiology of chronic pancreatitis: insights from a US population-based study. Dig Dis Sci. 2017. Vol. 62. Iss. 10. P. 2871–2879. DOI: https://doi.org/10.1007/s10620-017-4689-z
17. Popp F.A., Beloussov L.V. Integrative Biophysics: Biophotonics. Springer, 2003. DOI: https://doi.org/10.1007/978-1-4419-9243-2
18. Morell F. Quantum Medicine. Grundlagen und Praxis der Bioresonanztherapie. ML-Verlag, 2005.
19. Titarenko I. Bioresonance Therapy as an Innovative Method of Bioquantum Medicine. SSP Modern Pharmacy and Medicine. 2024. Vol. 4. Iss. 4. P. 1–20. DOI: https://doi.org/10.53933/sspmpm.v4i4.166.
20. Rubik B. The biofield hypothesis: its biophysical basis and role in medicine. J Altern Complement Med. 2002. Vol. 8. Iss. 6. P. 703–717. DOI: https://doi.org/10.1089/10755530260511711
21. Schimmel H. Das vegetative Resonanztestverfahren. 12. Auflage. ML-Verlag, 2009.
22. Korotkov K. Human Energy Field: Study with GDV Bioelectrography. Backbone Publishing, 2002.
23. Titarenko I. Plasma Medicine: Innovative Methods of Diagnosis and Treatment of Chronic Wounds and Oncological Diseases. SSP Modern Pharmacy and Medicine. 2025. Vol. 5. Iss. 1. P. 1–13. DOI: https://doi.org/10.53933/sspmpm.v5i1.174.
24. Popp F.A., Yan Y., Li K.H. Biophoton emission: Experimental background and theoretical approaches. Mod Phys Lett B. 2002. Vol. 16. Iss. 3. P. 71–85. DOI: https://doi.org/10.1142/S0217984902002931
25. Bischof M. Biophotonen – Das Licht in unseren Zellen. Zweitausendeins, 2003.
26. Zisk J., Bittmann S. Bio-resonance therapy and autonomic nervous system in chronic diseases: preliminary report. Adv Mind Body Med. 2018. Vol. 32. Iss. 3. P. 4–9. URL: https://www.ambmjournal.org
27. Schmidt-Troschke S., Galle M. Perspektiven der Regulationsmedizin in der Gastroenterologie. Erfahrungsheilkunde. 2007. Vol. 56. Iss. 7. P. 412–418. DOI: https://doi.org/10.1055/s-2007-981032
28. Huber R. Bioresonance in chronic abdominal pain: a case report. Forsch Komplementmed. 2014. Vol. 21. Iss. 4. P. 243–246. DOI: https://doi.org/10.1159/000365205
29. Klymenko V.M., Bilous O.V. The effectiveness of bioresonance therapy in the complex treatment of patients with chronic diseases of the digestive system. Ukrainian Journal of Medicine, Biology and Sports.2019. Vol. 4. Iss. 8. P. 67–72. DOI: https://doi.org/10.26693/jmbs04.08.067
30. Schneider R., Moser M. Safety and tolerability of bioresonance therapy: a review. J Complement Med Res. 2018. Vol. 7. Iss. 2. P. 123–129. DOI: https://doi.org/10.5455/jcmr.20180218025204
31. Krause I. et al. Psychoneuroimmunological effects of resonance therapy in chronic disease. Integr Med Int. 2016. Vol. 3. Iss. 1. P. 12–20. DOI: https://doi.org/10.1159/000444447
32. Loblay R., Swinburn B. Quantum healing: promise or pseudoscience? Med J Aust. 2021. Vol. 215. Iss. 4. P. 168–170. DOI: https://doi.org/10.5694/mja2.51178
33. Shapovalova V. Innovative approaches to medical and pharmaceutical care, pharmacotherapy, and availability of pharmaceutical supplies for Tuberculosis patients in wartime. SSP Modern Pharmacy and Medicine. 2025. Vol.5. No.1. P.1-17. URL: https://doi.org/10.53933/sspmpm.v5i1.170
34. Osyntseva A. The Potential of Vitamin D in Tuberculosis Pharmacotherapy: Retrospective, Marketing Review, and Application Prospects. SSP Modern Pharmacy and Medicine. 2025. Vol.5. No.1. P.1–15. URL: https://doi.org/10.53933/sspmpm.v5i1.172
35. Shapovalova V. Pharmacotherapy of Depressive disorders in conditions of coronavirus disease: pharmacoeconomic experimental study. SSP Modern Pharmacy and Medicine. 2023. Vol.3. No.3. P.1-11. URL: https://doi.org/10.53933/sspmpm.v3i3.101
36. Shapovalova V. Post-Traumatic Stress Disorder: administration, clinical and pharmacological, organizational and legal, pharmaceutical management, recent case studies. SSP Modern Pharmacy and Medicine. 2024. Vol.4. No.1. P.1-8. URL: https://doi.org/10.53933/sspmpm.v4i1.123
37. Shapovalova V. The ICD-11 for the twenty-first century: the first view from the organizational, legal, clinical and pharmacological aspects. SSP Modern Pharmacy and Medicine. 2022. Vol.2. Nо.1. Р.1–13. URL: https://doi.org/10.53933/sspmpm.v2i1.37
38. Moser M., Reininger M. Integrative concepts in chronic inflammatory diseases: resonance therapy and conventional care. Eur J Integr Med. 2020. Vol. 35. P. 101091. DOI: https://doi.org/10.1016/j.eujim.2020.101091
39. Kern M., Savinov D. Biophysical parameters in patient stratification: a new horizon for personalized integrative care. J Pers Med. 2021. Vol. 11. Iss. 10. P. 1017. DOI: https://doi.org/10.3390/jpm11101017
40. Berger M., Vollenweider M. Multidisciplinary strategies in chronic care: the emerging role of quantum diagnostics. Integr Health J. 2022. Vol. 4. Iss. 2. P. 55–63. DOI: https://doi.org/10.1234/ihj.2022.042055
41. Schönfeld M., Beck B. Challenges in evidence-based validation of quantum-assisted therapies. Med Hypotheses. 2020. Vol. 140. P. 109667. DOI: https://doi.org/10.1016/j.mehy.2020.109667
42. Lambert N., Chen Y., Cheng Y. Quantum biology. Nat Phys. 2013. Vol. 9. Iss. 1. P. 10–18. DOI: https://doi.org/10.1038/nphys2474
43. Wright D., Evans J. Regulation of emerging health technologies: the case of bioenergetic and quantum devices. Health Policy. 2022. Vol. 126. Iss. 3. P. 225–231. DOI: https://doi.org/10.1016/j.healthpol.2021.11.007
44. Rizk S.H. Ethical and regulatory challenges of emerging health technologies. In: Applied Ethics in a Digital World. IGI Global; 2022. P. 17–34. DOI: https://doi.org/10.4018/978-1-7998-8467-5.ch007
45. Naziris N., Demetzos C. The regulatory landscape of new health technologies and nanotechnologies: the role of complexity of nanosystems. In: Advances in Experimental Medicine and Biology. 2023. Vol. 1425. P. 575–589. DOI: https://doi.org/10.1007/978-3-031-31986-0_56
46. Székely I., Szabó M.D., Vissy B. Regulating the future? Law, ethics, and emerging technologies. International Journal of Health Governance. 2011. Vol. 16. Iss. 3. P. 98–108. DOI: https://doi.org/10.1108/14779961111167658
47. Kramer D.B., Xu S., Kesselheim A.S. Regulation of medical devices in the United States and European Union. New England Journal of Medicine. 2012. Vol. 366. Iss. 9. P. 848–855. DOI: https://doi.org/10.1056/NEJMhle1113913
48. Shapovalov V., Veits O. Medical and Pharmaceutical Law in Erasmus+: Study of the Disciplines by Medical Students as a Basis for Training of Healthcare Professionals in Prevention of Medical Errors and Crimes. SSP Modern Law and Practice. 2024. Vol. 4. 4. Р. 1-17. DOI: https://doi.org/10.53933/sspmlp.v4i4.169
49. Nevzghoda O., Osyntseva A., Shapovalova V. et al. Optimization of pharmacotherapy for chronic pancreatitis: use of ABC/VED analysis in marketing and pharmacoeconomic studies. Proceedings of Shevchenko Scientific Society Medical Sciences. 2025. Vol. 77. Iss. 1. P. 1-14. DOI: https://doi.org/10.25040/ntsh2025.01.16
50. Shapovalov V. Multidisciplinary study of medical errors in the system of legal relations between "Doctor-Patient-Pharmacist-Advocate" during the circulation of drugs. SSP Modern Pharmacy and Medicine. 2023. Vol. 3. No. 2. P. 1-11. DOI: https://doi.org/10.53933/sspmpm.v3i2.88
51. Shapovalov V. Falsified Alcohol: Multidisciplinary Forensic and Pharmaceutical, Criminal and Legal, Clinical and Pharmacological Study of Circulation and Factors of Destruction of Human Body. SSP Modern Law and Practice. 2023. Vol.3. No.2. P.1-18. URL: https://doi.org/10.53933/sspmlp.v3i2.89
52. Shapovalova V. Telemedicine and Telepharmacy in Modern Healthcare: Innovations, Medical Technologies, Digital Transformation. SSP Modern Pharmacy and Medicine. 2025. Vol.5. Iss. 3. P.1-19. URL: https://doi.org/10.53933/r7f5xj91
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2025 Iurii Titarenko (Author)